| P50 | author | Jeffrey Lieberman | Q6176130 |
| | Deanna M. Barch | Q24580798 |
| | Michael P. Harms | Q37385586 |
| | Lei Wang | Q37385604 |
| | Martin Styner | Q42390268 |
| P2093 | author name string | Daniel Mamah | |
| P2860 | cites work | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection | Q30386608 |
| | Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective | Q30581772 |
| | Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data | Q30711472 |
| | Computer-assisted imaging to assess brain structure in healthy and diseased brains | Q30810182 |
| | Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies | Q31023592 |
| | Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 |
| | Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies | Q32082435 |
| | Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders | Q33555684 |
| | Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia | Q33712210 |
| | Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type | Q33783383 |
| | Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia | Q33791461 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | Meta-analysis of regional brain volumes in schizophrenia | Q33885349 |
| | The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications | Q33979202 |
| | The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 |
| | Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia | Q34002498 |
| | The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect | Q48093348 |
| | The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients | Q48131062 |
| | Hippocampal and amygdala volume reductions in first-episode schizophrenia | Q48257402 |
| | Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study | Q48280427 |
| | Magnetic resonance imaging of brain in people at high risk of developing schizophrenia | Q48281246 |
| | The reduced neuropil hypothesis: a circuit based model of schizophrenia | Q48303124 |
| | Striatal enlargement in rats chronically treated with neuroleptic. | Q48361967 |
| | Hippocampal volume reduction in male schizophrenic patients | Q48418958 |
| | Temporal lobe abnormalities in first-episode psychosis | Q48564520 |
| | Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography | Q48609948 |
| | 15. Follow up MRI study in first episode schizophrenia | Q48647977 |
| | Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia | Q48660056 |
| | Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients | Q48704137 |
| | A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. | Q48752276 |
| | Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders | Q48875699 |
| | Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. | Q51029092 |
| | Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. | Q51410350 |
| | Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics. | Q51913418 |
| | Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. | Q52013919 |
| | Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. | Q52014690 |
| | Boundary and medial shape analysis of the hippocampus in schizophrenia | Q56797919 |
| | Duration of psychosis and outcome in first-episode schizophrenia | Q68016105 |
| | Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs | Q72692455 |
| | Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas | Q73028408 |
| | Schizophrenia is (not simply) a neurodevelopmental disorder | Q73528512 |
| | Temporolimbic volume reductions in schizophrenia | Q74091279 |
| | What would the patient choose? Subjective comparison of atypical and typical neuroleptics | Q82919725 |
| | Statistical analysis of hippocampal asymmetry in schizophrenia | Q34086913 |
| | Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. | Q34113051 |
| | Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. | Q34160826 |
| | Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia | Q34383654 |
| | Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. | Q34408719 |
| | Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 |
| | Statistical methods in computational anatomy | Q34443351 |
| | Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals | Q34492046 |
| | Glutamate receptor dysfunction and schizophrenia | Q34719075 |
| | Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? | Q34809553 |
| | Morphometry of the hippocampus and amygdala in bipolar disorder and schizophrenia | Q35704395 |
| | Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change | Q35926004 |
| | Cognition, schizophrenia, and the atypical antipsychotic drugs | Q36086075 |
| | Hippocampal morphometry in schizophrenia by high dimensional brain mapping. | Q36311139 |
| | Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. | Q37446674 |
| | Gender differences in age effect on brain atrophy measured by magnetic resonance imaging | Q37464725 |
| | The Hippocampal Formation in Schizophrenia | Q37784600 |
| | Hippocampal pathology in schizophrenia. | Q37839953 |
| | Cognitive substrates of thought disorder, I: the semantic system | Q38451472 |
| | Antipsychotic drugs, neurotransmitters, and schizophrenia | Q39180903 |
| | Hippocampal MR imaging morphometry by means of general pattern matching | Q39422133 |
| | Longitudinal study of brain morphology in first episode schizophrenia | Q40718665 |
| | Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study | Q40858744 |
| | Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain | Q41720304 |
| | Why do delusions persist? | Q42103369 |
| | Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum | Q42276301 |
| | Atypical neuroleptics stimulate neurogenesis in adult rat brain | Q44059818 |
| | Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs | Q44246562 |
| | Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents | Q44259205 |
| | Cerebral metabolism and risperidone treatment in schizophrenia | Q44264699 |
| | The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. | Q44393719 |
| | Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity | Q44442303 |
| | Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex | Q44603419 |
| | Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus | Q44793041 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 96 | |
| P577 | publication date | 2012-11-12 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness | |
| P478 | volume | 3 | |